Keyphrases
Anti-apoptotic
8%
BIRC5
8%
Blood Samples
8%
C-X-C Chemokine Receptor Type 4 (CXCR4)
8%
Cancer Center
8%
Cell Adhesion
100%
Chromatin Acetylation
8%
Chromatin Immunoprecipitation (ChIP)
8%
Clinical Decision-making
8%
Cutaneous T-cell Lymphoma
100%
Epigenetic Modifiers
8%
Gene Expression
16%
GSTM1
8%
H3K14
8%
H3K27ac
8%
Histone Acetylation
33%
Histone Deacetylase Inhibitor (HDACi)
100%
Inhibitor Resistance
100%
Inhibitor Resistant
16%
Inhibitor Response
8%
Inhibitor Therapy
8%
LAIR2
33%
Lymphoma Patients
25%
Microarray
8%
Migration Routes
100%
Molecular Markers
8%
NCATS
8%
Patient Cohort
8%
Patient Plasma
16%
Peripheral Blood
8%
Predictive Marker
100%
Primary Cutaneous T-cell Lymphoma
8%
Redox
8%
RNA Sequencing (RNA-seq)
16%
RRM2
8%
Skin Biopsy
8%
T Cells
8%
TXNDC5
8%
Neuroscience
Acetylation
7%
Blood Plasma
14%
Cell Adhesion
100%
Cell Cycle
7%
Clinical Decision Making
7%
CXCR4
7%
ELISA
7%
Gene Expression
14%
Histone Acetylation
28%
Histone Deacetylase Inhibitor
100%
RNA-Seq
14%
T Cell
100%
Biochemistry, Genetics and Molecular Biology
Acetylation
7%
Blood Plasma
14%
Cell Adhesion
100%
Cell Cycle
7%
Clinical Decision Making
7%
CXCR4
7%
Epigenetics
7%
Gene Expression
14%
Genetic Marker
7%
Histone Acetylation
28%
Histone Deacetylase
50%
RNA Sequencing
14%
RRM2
7%
T Cell
100%